165 related articles for article (PubMed ID: 35364740)
21. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
22. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
[TBL] [Abstract][Full Text] [Related]
23. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
Kaneno R; Shurin GV; Kaneno FM; Naiditch H; Luo J; Shurin MR
Cell Oncol (Dordr); 2011 Apr; 34(2):97-106. PubMed ID: 21290210
[TBL] [Abstract][Full Text] [Related]
25. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
[TBL] [Abstract][Full Text] [Related]
26. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
27. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
[TBL] [Abstract][Full Text] [Related]
28. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cell biology and its role in tumor immunotherapy.
Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation of antigen processing machinery components and association with cervical carcinoma.
Mehta AM; Jordanova ES; van Wezel T; Uh HW; Corver WE; Kwappenberg KM; Verduijn W; Kenter GG; van der Burg SH; Fleuren GJ
Genes Chromosomes Cancer; 2007 Jun; 46(6):577-86. PubMed ID: 17366619
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
33. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
Compagnone M; Cifaldi L; Fruci D
Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
[TBL] [Abstract][Full Text] [Related]
34. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
35. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
36. [Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A].
Murtadha AH; Sharudin NA; Azahar IIM; Che Has AT; Mokhtar NF
Mol Biol (Mosk); 2023; 57(6):21-30. PubMed ID: 38062971
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
39. Shedding new light on the role of ERAP1 in Type 1 diabetes: A perspective on disease management.
Paldino G; Fierabracci A
Autoimmun Rev; 2023 Apr; 22(4):103291. PubMed ID: 36740089
[TBL] [Abstract][Full Text] [Related]
40. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
López-Albaitero A; Nayak JV; Ogino T; Machandia A; Gooding W; DeLeo AB; Ferrone S; Ferris RL
J Immunol; 2006 Mar; 176(6):3402-9. PubMed ID: 16517708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]